IL129635A - Antimalarial compositions containing cis-fused cyclopenteno-1,2,4-trioxane derivatives - Google Patents
Antimalarial compositions containing cis-fused cyclopenteno-1,2,4-trioxane derivativesInfo
- Publication number
- IL129635A IL129635A IL12963597A IL12963597A IL129635A IL 129635 A IL129635 A IL 129635A IL 12963597 A IL12963597 A IL 12963597A IL 12963597 A IL12963597 A IL 12963597A IL 129635 A IL129635 A IL 129635A
- Authority
- IL
- Israel
- Prior art keywords
- component
- trioxane
- compound
- drug combination
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9622427.4A GB9622427D0 (en) | 1996-10-28 | 1996-10-28 | Antimalarial drugs |
| PCT/GB1997/002974 WO1998018462A1 (en) | 1996-10-28 | 1997-10-28 | Antimalarial compositions containing cis-fused cyclopenteno-1,2,4-trioxane derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL129635A0 IL129635A0 (en) | 2000-02-29 |
| IL129635A true IL129635A (en) | 2002-05-23 |
Family
ID=10802068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12963597A IL129635A (en) | 1996-10-28 | 1997-10-28 | Antimalarial compositions containing cis-fused cyclopenteno-1,2,4-trioxane derivatives |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5834505A (de) |
| EP (1) | EP0938306B1 (de) |
| JP (1) | JP2001507672A (de) |
| AT (1) | ATE224709T1 (de) |
| AU (1) | AU738885B2 (de) |
| CA (1) | CA2270138A1 (de) |
| DE (1) | DE69715895T2 (de) |
| DK (1) | DK0938306T3 (de) |
| ES (1) | ES2183146T3 (de) |
| GB (1) | GB9622427D0 (de) |
| IL (1) | IL129635A (de) |
| NZ (1) | NZ335451A (de) |
| OA (1) | OA11039A (de) |
| PT (1) | PT938306E (de) |
| WO (1) | WO1998018462A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN191696B (de) * | 1999-02-12 | 2003-12-20 | Council Scient Ind Res | |
| EP1261340B1 (de) | 1999-07-13 | 2009-05-13 | Alpha Research Group, LLC | Zusammensetzungen und verfahren zur behandlung der parkinson-krankheit |
| US20040229908A1 (en) * | 1999-07-13 | 2004-11-18 | Jodi Nelson | Compositions and methods for the treatment of Parkinson's disease and tardive dyskinesias |
| US8784881B2 (en) * | 2004-03-05 | 2014-07-22 | Board Of Regents, The University Of Texas System | Liposomal curcumin for treatment of diseases |
| EP2200611A4 (de) | 2007-09-14 | 2010-09-22 | Biogen Idec Inc | Zusammensetzungen und verfahren zur behandlung von progressiver multifokaler leukoenzephalopathie (pml) |
| US20180055835A1 (en) | 2016-08-25 | 2018-03-01 | Immune Therapeutics Inc. | Method for Treating And Preventing Protozoal Infections |
| KR102491180B1 (ko) | 2017-04-27 | 2023-01-20 | 파르마 마르 에스.에이. | 항종양 화합물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH672734A5 (de) * | 1987-04-03 | 1989-12-29 | Charles W Jefford | |
| IN166154B (de) * | 1987-05-08 | 1990-03-24 | Hoechst India | |
| SU1689336A1 (ru) * | 1989-05-03 | 1991-11-07 | Akhmedzyanov Maksut M | Композици дл изготовлени строительных материалов |
| NZ246606A (en) * | 1992-02-07 | 1995-09-26 | Ciba Geigy Ag | Antimalarial compostions containing a synergistic combination of benflumetol and quinine or a derivative thereof |
-
1996
- 1996-10-28 GB GBGB9622427.4A patent/GB9622427D0/en active Pending
- 1996-11-15 US US08/752,454 patent/US5834505A/en not_active Expired - Fee Related
-
1997
- 1997-10-28 DK DK97910531T patent/DK0938306T3/da active
- 1997-10-28 DE DE69715895T patent/DE69715895T2/de not_active Expired - Fee Related
- 1997-10-28 ES ES97910531T patent/ES2183146T3/es not_active Expired - Lifetime
- 1997-10-28 PT PT97910531T patent/PT938306E/pt unknown
- 1997-10-28 EP EP97910531A patent/EP0938306B1/de not_active Expired - Lifetime
- 1997-10-28 CA CA002270138A patent/CA2270138A1/en not_active Abandoned
- 1997-10-28 WO PCT/GB1997/002974 patent/WO1998018462A1/en not_active Ceased
- 1997-10-28 NZ NZ335451A patent/NZ335451A/en unknown
- 1997-10-28 JP JP52020098A patent/JP2001507672A/ja active Pending
- 1997-10-28 AT AT97910531T patent/ATE224709T1/de not_active IP Right Cessation
- 1997-10-28 AU AU47880/97A patent/AU738885B2/en not_active Ceased
- 1997-10-28 IL IL12963597A patent/IL129635A/en not_active IP Right Cessation
-
1999
- 1999-04-28 OA OA9900089A patent/OA11039A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5834505A (en) | 1998-11-10 |
| GB9622427D0 (en) | 1997-01-08 |
| EP0938306A1 (de) | 1999-09-01 |
| IL129635A0 (en) | 2000-02-29 |
| PT938306E (pt) | 2002-12-31 |
| AU4788097A (en) | 1998-05-22 |
| CA2270138A1 (en) | 1998-05-07 |
| NZ335451A (en) | 2001-02-23 |
| JP2001507672A (ja) | 2001-06-12 |
| AU738885B2 (en) | 2001-09-27 |
| DE69715895T2 (de) | 2003-07-31 |
| ES2183146T3 (es) | 2003-03-16 |
| DE69715895D1 (de) | 2002-10-31 |
| EP0938306B1 (de) | 2002-09-25 |
| OA11039A (en) | 2003-03-07 |
| WO1998018462A1 (en) | 1998-05-07 |
| DK0938306T3 (da) | 2003-01-13 |
| ATE224709T1 (de) | 2002-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chawira et al. | The effect of combinations of qinghaosu (artemisinin) with standard antimalarial drugs in the suppressive treatment of malaria in mice | |
| Peters | The evolution of tafenoquine—antimalarial for a new millennium? | |
| AU642747B2 (en) | Antimalarial compositions | |
| Kumar et al. | Perspective in antimalarial chemotherapy | |
| Cook | Prevention and treatment of malaria | |
| US4260615A (en) | Antimalarial compositions | |
| Wang et al. | Naphthoquine phosphate and its combination with artemisinine | |
| JPH02157223A (ja) | 抗マラリア剤組成物 | |
| Fernandes et al. | Antiprotozoal agents: How have they changed over a decade? | |
| HU200688B (en) | Process for producing pharmaceutical composition against malaria | |
| US5834505A (en) | Antimalarial drugs | |
| Bunnag et al. | Double blind randomised clinical trial of two different regimens of oral artesunate in falciparum malaria | |
| EA012630B1 (ru) | Комбинация феррохина и производного артемизинина для лечения малярии | |
| Sutherland et al. | The addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children delays, but does not prevent treatment failure. | |
| WO2005023304A2 (en) | Antimalarial compositions and manufacturing process thereof | |
| Dutta et al. | Study of the gametocytocidal/sporontocidal action of qinghaosu (artemisinin) by electron microscopy | |
| Sharma et al. | A review on anti malarial drug | |
| Peters et al. | The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines | |
| Barber | Chloroquine and hydroxychloroquine | |
| Craige et al. | Clinical Standardization of Pamaquin (Plasmochin) in Mosquito-Induced Vivax Malaria, Chesson Strain: A Preliminary Report | |
| Nicanor Obaldía | The human malaria-Aotus monkey model: a historical perspective in antimalarial chemotherapy research at the Gorgas Memorial Laboratory-Panama | |
| JP2011037814A (ja) | マラリア原虫疾患予防又は治療用の５−ヘテロ環置換イミノ−９−ジアルキルアミノベンゾ［ａ］フェノキサチン化合物又はその塩とアーテミシニン誘導体との組み合わせ | |
| Peters et al. | The chemotherapy of rodent malaria. LIX. Drug combinations to impede the selection of drug resistance, part 3: observations on cyproheptadine, an antihistaminic agent, with chloroquine | |
| EP0464233A1 (de) | Pharmzeutische Mischungen gegen Malaria | |
| WO1999025351A1 (fr) | Compositions pharmaceutiques antipaludiques |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |